This week's science news featured some big headlines for health, including the landmark decision to officially rename polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS).
The name change — the culmination of a 14-year process that took input from over 14,000 patients and health professionals — was made to better reflect the nature of the disease from one that implied (incorrectly) that people with the disease have a higher number of pathological noncancerous ovarian cysts than those without the condition. Instead, those with PMOS have a large number of "arrested follicles," or ovarian eggs that have failed to fully mature.
